Metoprolol Succinate ER Tablet 200 mg

DRUG2 trials

Sponsors

IPCA Laboratories Ltd.

Conditions

FastingFed

Phase 1

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions

CompletedNCT01884896

IPCA Laboratories Ltd.Fasting

Start: 2013-02-28End: 2013-03-31Updated: 2013-06-24

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions

CompletedNCT01884909

IPCA Laboratories Ltd.Fed

Start: 2013-04-30End: 2013-05-31Updated: 2013-06-24